Archives for 2021

PHAR’s Sheila Reiss Reddy, PhD, RPh, and Eunice Chang, PhD, in collaboration with GRAIL, analyzed 2012-2016 data from the linked SEER registry-Medicare claims database calculating and comparing the cancer-related costs of 17 cancers by stage of diagnosis. Their findings show patients diagnosed at later stages of cancer have higher costs of care (up to 7 times as much) than those diagnosed at earlier stages. Earlier cancer diagnosis may lead to more efficient treatment and decreased management cost. A poster detailing the findings was presented at the Annual Conference of the Hematology/Oncology Pharmacy Association and can be viewed here, and the abstract was published in the March 2021 special feature issue of the Journal of Hematology/Oncology Pharmacy.

PHAR’s Sheila Reiss Reddy, PhD, RPh, Eunice Chang, PhD, and Caleb Paydar, BS, in conjunction with Genentech, Inc., presented the results of two studies of Huntington’s disease in Medicaid beneficiaries. Their first study compared healthcare utilization and costs among US Medicaid beneficiaries with Huntington’s disease to those without Huntington’s disease. They also presented a study on the burden of illness among US Medicare beneficiaries with late-onset Huntington’s disease. The abstracts were published in the April 2021 supplement issue of the Journal of Managed Care & Specialty Pharmacy, and the posters can be found on the PHAR publications page.